Key Highlights
- Amazon shares peaked at a record $258.79, representing a 41.4% annual increase
- Current trading price hovers close to InvestingPro’s calculated Fair Value of $258.38
- BMO Capital elevated its target to $315, projecting AWS momentum through the first half of 2026
- The company committed another $5 billion to Anthropic, planning $20 billion in additional funding
- Ad revenue positioned for growth from major sporting events including Winter Olympics and FIFA World Cup
Shares of Amazon touched $258.79 during Wednesday’s trading session, marking a fresh record for the e-commerce and cloud computing giant. The stock has climbed 41.4% across the trailing twelve months, pushing the company’s valuation to approximately $2.78 trillion.
According to InvestingPro analytics, Amazon’s Fair Value stands at $258.38, suggesting the stock is trading near equilibrium at present levels. The investment platform assigns Amazon a “GREAT” rating for overall financial health.
On Wednesday morning, BMO Capital upgraded its price objective on AMZN from $310 to $315 while maintaining an Outperform designation. The investment bank also confirmed Amazon remains among its Top Pick selections.
BMO’s industry research indicates AWS is experiencing accelerating expansion heading into the first half of 2026. This uptick stems partly from robust demand coming from artificial intelligence laboratories and recent enhancements to supply chain efficiency.
The firm expressed some reservations regarding the retail division. Macroeconomic volatility and geopolitical tensions pose risks to retail performance, although consumer spending remains resilient for now.
Cloud Computing and Artificial Intelligence Investments
Amazon’s deepened collaboration with Anthropic has captured significant analyst interest. The tech giant injected another $5 billion into the AI startup, with plans for $20 billion more. Anthropic has pledged to allocate over $100 billion toward AWS services throughout the coming decade.
UBS likewise increased its Amazon price objective to $304 from a previous level, maintaining its Buy recommendation. The firm emphasized recently announced AWS agreements with both OpenAI and Anthropic as significant catalysts for revenue expansion.
Roth/MKM confirmed its Buy stance with a $285 price objective. Cantor Fitzgerald elevated its target to $280, highlighting robust AWS acceleration fueled by AI laboratory requirements and supply chain optimization.
Truist Securities preserved its Buy rating as well, emphasizing the Anthropic alliance as a pivotal growth engine.
Diversification Beyond Cloud Services
Regarding advertising operations, BMO Capital modestly increased its projections for this segment. The firm anticipates a particularly favorable 2026, with the Winter Olympics, FIFA World Cup, and election activities all contributing positive momentum.
Amazon revealed a collaboration with Swedish firm Einride to introduce 75 electric heavy-duty vehicles across five domestic facilities. These trucks will operate under Einride’s Saga AI platform, which coordinates charging schedules and fleet management.
This week, Amazon unveiled a weight management initiative through Amazon One Medical, integrating GLP-1 medications with primary care offerings. The announcement adversely affected Hims & Hers Health share prices.
Amazon’s next earnings disclosure is set for April 29. InvestingPro analysts have identified 12 ProTips for investors evaluating the stock before that announcement. The equity currently commands a P/E ratio of 35.48.
As of Wednesday’s close, AMZN traded at $255.36, just below its fresh 52-week peak of $258.79.
